Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW679769 vs Placebo in Women with Overactive Bladder
NCT00321477Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in overactive bladder (OAB) comparing GW679769 Arm with Placebo Arm (2 arms). Primary endpoint: Percent change from baseline in the number of incontinence episodes per 24 hours at 12 weeks. Started Dec 2005; status: completed.
02
Drugs
casopitant
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00321477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321477.